ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

Reviews of the Faculty Report by Irwin Krakoff, Robert Cook-Deegan, and Michael Katz

March 29, 2013

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983

Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says

February 20, 1998

Case Western Wins Renewal.

October 5, 2001

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007